W. Fujimoto et al., EXPRESSION OF CORNIFIN IN SQUAMOUS DIFFERENTIATING EPITHELIAL TISSUES, INCLUDING PSORIATIC AND RETINOIC ACID-TREATED SKIN, Journal of investigative dermatology, 101(3), 1993, pp. 268-274
The expression of cornifin, a putative cross-linked envelope precursor
, was investigated in several squamous differentiating tissues by in s
itu hybridization and immunohistochemical analysis. Cornifin mRNA and
protein, which are absent in the normal mucociliary tracheal epitheliu
m, are induced in the suprabasal layers of the squamous metaplastic tr
acheal epithelium of vitamin A - deficient hamsters. Similar to the in
duction of squamous metaplasia in vivo, culture of rabbit tracheal cel
ls in the absence of retinoids results in squamous differentiation and
expression of cornifin. This induction of cornifin expression is supp
ressed by retinoic acid and several of its analogs. Cornifin mRNA and
protein are also detected in the suprabasal layers of the squamous epi
thelium of rabbit esophagus and tongue. The distribution of cornifin i
n human epidermis was compared with that of two other crosslinked enve
lope precursor proteins, involucrin and loricrin. The localization of
cornifin and involucrin is very similar. Both are induced in the spino
us layer and appear at an earlier stage during epidermal differentiati
on than loricrin. The expression of cornifin is greatly increased in p
soriatic skin. Cornifin mRNA is barely detectable in normal epidermis,
whereas it is present at relatively high levels in the suprabasal lay
ers of psoriatic epidermis. Topical treatment with RA results in thick
ening of the skin and increases the level of cornifin mRNA and protein
in the upper spinous layers of mouse skin. Cornifin expression correl
ates generally with squamous differentiation in a variety of tissues a
nd is abnormally regulated in psoriatic skin and in skin treated topic
ally with retinoic acid.